Jul 25, 2018   SOURCE: PR NewsWire

Epiomic Epidemiology Report: Onychomycosis Forecast In 22 Major Markets 2018-2028

DUBLIN, July 25, 2018 /PRNewswire/ --

The "Epiomic Epidemiology Series: Onychomycosis Forecast In 22 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Onychomycosis is a fungal infection of the nail which occurs in the hands or feet. The more notable causative agents include the fungal pathogens Trichophyton rubrum and Trichophyton mentagrophytes.

This report provides the current prevalent population for Onychomycosis across 22 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Sweden, Denmark, Finland, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort.

Along with the current prevalence, the report also contains a disease overview of the risk factors and prevention, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from our analysis team, patient groups divided by disease classification, aetiology, main symptoms and co-morbidities have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Onychomycosis include:

    --  Diabetes
    --  Tinea pedis
    --  Peripheral vascular disease
    --  HIV / AIDS
    --  Psoriasis
    --  Hypercholesterolaemia
    --  Osteoarticular disease

Reasons to buy

    --  Able to quantify patient populations in global Onychomycosis market to
        target the development of future products, pricing strategies and launch
        plans.
    --  Gain further insight into the prevalence of the subdivided types of
        Onychomycosis and identify patient segments with high potential.
    --  Delivery of more accurate information for clinical trials in study
        sizing and realistic patient recruitment for various countries.
    --  Useful in the identification and trend of the prevalence numbers for the
        different causative agents of Onychomycosis.
    --  Provide a level of understanding on the impact from specific co-morbid
        conditions on Onychomycosis prevalent population.
    --  Identify sub-populations within Onychomycosis which require treatment.
    --  Gain an understanding of the specific markets that have the largest
        number of Onychomycosis patients.

Key Topics Covered: 

    1. Introduction
    2. Cause Of The Disease
    3. Risk Factors & Prevention
    4. Diagnosis Of The Disease
    5. Variation By Geography/Ethnicity
    6. Disease Prognosis & Clinical Course
    7. Key Comorbid Conditions / Features Associated With The Disease
    8. Methodology For Quantification Of Patient Numbers
    9. Top-Line Prevalence For Onychomycosis
    10. Features Of Onychomycosis Patients
    11. Abbreviations Used In The Report
    12. Other Services & Solutions
    13. Reports & Publications
    14. Online Epidemiology Databases
    15. Online Pharmaceutical Pricing Database
    16. References

    17. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/c7h269/epiomic?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/epiomic-epidemiology-report-onychomycosis-forecast-in-22-major-markets-2018-2028-300686431.html

SOURCE Research and Markets